Journal article
393 A phase II study of OSI-774 given in combination with carboplatin in patients with recurrent ovarian cancer (NCIC IND.149)
Authors
Hirte H; Swenerton K; Oza A; Ellard S; Plante M; Grimshaw R; Carey M; Seymour L; Fisher B; Walsh W
Journal
European Journal of Cancer Supplements, Vol. 2, No. 8,
Publisher
Elsevier
Publication Date
September 1, 2004
DOI
10.1016/s1359-6349(04)80400-2
ISSN
1359-6349